As of November 2026 Genmab has a market cap of โฌ30.61 Billion. This makes Genmab the world's 723th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 8th, 2026 the market cap of Genmab was reported to be: